Cargando…
Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety
Current researches have showed that N3, N5-diaryl-2, 6-dimethyl -1, 4-dihydropyrine-3, 5- dicarboxamide analogues demonstrate notable anti-tubercular activity. In this study, Hantzsch condensation was used to design and synthesize new analogues of dihydropyridine (DHP). Different diary carboxamides...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316257/ https://www.ncbi.nlm.nih.gov/pubmed/28243275 |
_version_ | 1782508817209098240 |
---|---|
author | Iman, Maryam Davood, Asghar Lotfinia, Mahboubeh Dehqani, Golnoush Sardari, Soroush Azerang, Parisa Amini, Mohsen |
author_facet | Iman, Maryam Davood, Asghar Lotfinia, Mahboubeh Dehqani, Golnoush Sardari, Soroush Azerang, Parisa Amini, Mohsen |
author_sort | Iman, Maryam |
collection | PubMed |
description | Current researches have showed that N3, N5-diaryl-2, 6-dimethyl -1, 4-dihydropyrine-3, 5- dicarboxamide analogues demonstrate notable anti-tubercular activity. In this study, Hantzsch condensation was used to design and synthesize new analogues of dihydropyridine (DHP). Different diary carboxamides were inserted at positions 3 and 5 of the DHP ring. 4(5)-chloro-2-ethyl-5(4)-imidazolyl moiety was considered at position 4 of the DHP ring. The structures of prepared ligands were characterized using TLC followed by FT-IR, elemental analysis, Mass and proton NMR. Results of anti-tubercular activity have indicated all the prepared ligands 3a-f inhibit the mycobacterium tuberculosis growth and the most potent compounds were 3c (3,4-Cl) and 3b (4-Cl). The in-vitro obtained data are agreement with our computational predictions in terms of partial atomic charge of carbonyl moieties at the positions 3 and 5 of dihydropyridine ring and the logP of the molecules. |
format | Online Article Text |
id | pubmed-5316257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-53162572017-02-27 Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety Iman, Maryam Davood, Asghar Lotfinia, Mahboubeh Dehqani, Golnoush Sardari, Soroush Azerang, Parisa Amini, Mohsen Iran J Pharm Res Original Article Current researches have showed that N3, N5-diaryl-2, 6-dimethyl -1, 4-dihydropyrine-3, 5- dicarboxamide analogues demonstrate notable anti-tubercular activity. In this study, Hantzsch condensation was used to design and synthesize new analogues of dihydropyridine (DHP). Different diary carboxamides were inserted at positions 3 and 5 of the DHP ring. 4(5)-chloro-2-ethyl-5(4)-imidazolyl moiety was considered at position 4 of the DHP ring. The structures of prepared ligands were characterized using TLC followed by FT-IR, elemental analysis, Mass and proton NMR. Results of anti-tubercular activity have indicated all the prepared ligands 3a-f inhibit the mycobacterium tuberculosis growth and the most potent compounds were 3c (3,4-Cl) and 3b (4-Cl). The in-vitro obtained data are agreement with our computational predictions in terms of partial atomic charge of carbonyl moieties at the positions 3 and 5 of dihydropyridine ring and the logP of the molecules. Shaheed Beheshti University of Medical Sciences 2016 /pmc/articles/PMC5316257/ /pubmed/28243275 Text en © 2016 by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Iman, Maryam Davood, Asghar Lotfinia, Mahboubeh Dehqani, Golnoush Sardari, Soroush Azerang, Parisa Amini, Mohsen Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety |
title | Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety |
title_full | Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety |
title_fullStr | Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety |
title_full_unstemmed | Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety |
title_short | Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety |
title_sort | design, synthesis and anti-tubercular activity of novel 1, 4-dihydropyrine-3, 5-dicarboxamide containing 4(5)-chloro-2-ethyl- 5(4)-imidazolyl moiety |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316257/ https://www.ncbi.nlm.nih.gov/pubmed/28243275 |
work_keys_str_mv | AT imanmaryam designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety AT davoodasghar designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety AT lotfiniamahboubeh designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety AT dehqanigolnoush designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety AT sardarisoroush designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety AT azerangparisa designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety AT aminimohsen designsynthesisandantitubercularactivityofnovel14dihydropyrine35dicarboxamidecontaining45chloro2ethyl54imidazolylmoiety |